Search research articles
Contact Us
Filters
Showing results (51-60 of 163) with videos related to
Page
of 17
Sort By:
Blood Cells, Molecules & Diseases
|
January 1, 1997
Hematologically important mutations: Glanzmann thrombasthenia
D L French, B S Coller
Methods in Enzymology
|
January 1, 1986
Poisson statistical analysis of repetitive subcloning by the limiting dilution technique as a way of assessing hybridoma monoclonality
H A Coller, B S Coller
Thrombosis and Haemostasis
|
May 6, 1998
Fibrinogen coating density affects the conformation of immobilized fibrinogen: implications for platelet adhesion and spreading
K A Moskowitz, B Kudryk, B S Coller
Science (New York, N.Y.)
|
April 2, 1976
Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants
H R Gralnick, B S Coller, Y Sultan
Blood
|
June 1, 1987
Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis
B S Coller, U Seligsohn, P A Little
Circulation
|
February 18, 1997
Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade
B S Coller, D Lang, L E Scudder
JAMA
|
September 17, 1982
Severe von Willebrand's disease during labor and delivery
R A Lipton, J Ayromlooi, B S Coller
The Journal of Clinical Investigation
|
October 1, 1975
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease
H R Gralnick, B S Coller, Y Sultan
Circulation
|
February 4, 1997
In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time
T Ammar, L E Scudder, B S Coller
Thrombosis and Haemostasis
|
July 1, 1995
New antiplatelet agents: platelet GPIIb/IIIa antagonists
B S Coller, K Anderson, H F Weisman
Page
of 17
Search research articles
Search
Showing results (51-60 of 163) with videos related to
Sort By:
Page
of 17
Blood Cells, Molecules & Diseases
|
January 1, 1997
Hematologically important mutations: Glanzmann thrombasthenia
D L French, B S Coller
Methods in Enzymology
|
January 1, 1986
Poisson statistical analysis of repetitive subcloning by the limiting dilution technique as a way of assessing hybridoma monoclonality
H A Coller, B S Coller
Thrombosis and Haemostasis
|
May 6, 1998
Fibrinogen coating density affects the conformation of immobilized fibrinogen: implications for platelet adhesion and spreading
K A Moskowitz, B Kudryk, B S Coller
Science (New York, N.Y.)
|
April 2, 1976
Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants
H R Gralnick, B S Coller, Y Sultan
Blood
|
June 1, 1987
Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis
B S Coller, U Seligsohn, P A Little
Circulation
|
February 18, 1997
Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade
B S Coller, D Lang, L E Scudder
JAMA
|
September 17, 1982
Severe von Willebrand's disease during labor and delivery
R A Lipton, J Ayromlooi, B S Coller
The Journal of Clinical Investigation
|
October 1, 1975
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease
H R Gralnick, B S Coller, Y Sultan
Circulation
|
February 4, 1997
In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time
T Ammar, L E Scudder, B S Coller
Thrombosis and Haemostasis
|
July 1, 1995
New antiplatelet agents: platelet GPIIb/IIIa antagonists
B S Coller, K Anderson, H F Weisman
Page
of 17